Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07661056 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
NotablePrimary endpoints: details revised at 1 of 1 entry
Trial sites expanded: 44 → 50 locations
Eligibility criteria expanded, about 9 words
Secondary endpoints: details revised at 2 of 12 entries
MinorTrial sites expanded: 40 → 44 locations
Trial sites expanded: 30 → 40 locations
v17
MinorStudy sites: 30 to 40
Eligibility criteria revised
Secondary endpoints revised (12)
v16
MinorTrial sites expanded: 24 → 28 locationsv15
MinorStudy sites: 24 to 28v14
MinorStudy sites: 23 to 24v13
MinorStudy sites: 21 to 23v12
MinorStudy sites: 20 to 21v11
MinorTrial sites expanded: 15 → 20 locationsv10
MinorStudy sites: 14 to 15v9
MinorStudy sites: 12 to 14v8
MinorTrial sites expanded: 8 → 11 locationsv7
MinorTrial sites expanded: 5 → 8 locationsv6
MinorStudy sites: 5 to 8v5
MinorTrial sites expanded: 2 → 5 locations
Start date changed from estimate of Jun 2026 to Jun 26, 2026
v4
MinorStudy sites: 1 to 2v3
NotableRecruitment opened
Study sites: 0 to 1
v2
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.